Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study.
Emilio IannittoAlessandra RomanoPotito Rosario ScalzulliVincenza BonannoRenato ScaloneAnnalisa ChiarenzaMaria Cristina PirosaAnastasia Laura CarusoCarla MinoiaSaverio MantuanoGaetano De SantisMarilena SalernoAlessandra CrescimannoFerdinando PorrettoFelicina Li GioiGiuseppina RicciutiAntonino GrecoEnzo PavoneAttilio GuariniGiuseppe TarantiniDonato ManninaUgo ConsoliNicola CascavillaFrancesco Di RaimondoMaurizio MussoPublished in: European journal of haematology (2020)
Our real-world results suggest that BvB is an effective third-line rescue and bridge-to-transplant regimen for RR-cHL patients.